Skip to main content

Judith Sacanell Lacasa

Institutions of which they are part

Shock, Organ Dysfunction and Resuscitation
Vall Hebron Institut de Recerca

Judith Sacanell Lacasa

Institutions of which they are part

Shock, Organ Dysfunction and Resuscitation
Vall Hebron Institut de Recerca

Projects

ADN CIRCULANTE COMO BIOMARCADOR NO INVASIVO TRAS UN TRASPLANTE DE PULMÓN

IP: Antonio Román Broto
Collaborators: Juliana Esperalba Esquerra, Carles Bravo Masgoret, Vanessa Casares Rodríguez, Judith Sacanell Lacasa, Cristina Berastegui Garcia, Manuel López Meseguer, Berta Saez Gimenez, Maria Martinez Martinez, Jordi Riera del Brío
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI17/01485
Duration: 01/01/2018 - 30/06/2022

Papel del eje IL-33 /ST2 en el diagnóstico, pronóstico y tratamiento del Síndrome de distrés respiratorio agudo

IP: -
Collaborators: César Laborda Soriano, Judith Sacanell Lacasa
Funding agency: Instituto de Salud Carlos III
Funding: 122815
Reference: PI14/01420
Duration: 01/01/2015 - 31/12/2017

Grup de Recerca en Sèpsia i Infecció Respiratoria Greu

IP: Jordi Rello Condomines
Collaborators: Elisabet Gallart Vive, Rosa Maria Gracia Gozalo, Juan Carlos Ruiz Rodriguez, Judith Sacanell Lacasa, Marcos Pérez Carrasco, Joan Balcells Ramirez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2009 SGR 1226
Duration: 01/01/2010 - 30/04/2014

Insuficienca respiratoria aguda (disfunción primaria del injerto y neumonía vs rechazo) en el postoperatorio en UCI del trasplante pulmonar (UCI-TRASP)

IP: Jordi Rello Condomines
Collaborators: Roser Anglès Coll, María Deu Martín, Judith Sacanell Lacasa, Jordi Riera del Brío, Teresa Pont Castellana
Funding agency: Instituto de Salud Carlos III
Funding: 222541.99
Reference: PI11/01122
Duration: 01/01/2012 - 31/12/2014

Related news

The study will be conducted in the Intensive Care Medicine Service of the Vall d’Hebron University Hospital and will validate the prognostic value of the NLRP3 biomarker.

SOFA-2 is being updated after thirty years to incorporate advances in diagnosis, monitoring and life support.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

Related professionals

Alicia San Juan Espiño

Alicia San Juan Espiño

Infectious Diseases
Read more
Emily Betancourt Fernández

Emily Betancourt Fernández

Predoctoral researcher
Molecular Imaging and Therapy
Read more
Lluis Tort Bardolet

Lluis Tort Bardolet

Research technician
Protein kinases in cancer research
Read more
Belen Sarto Guerri

Belen Sarto Guerri

Research technician
Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.